Arnika health

Arnika Health is a biotechnology company focused on the development of novel therapeutic agents for the treatment of inflammatory and autoimmune conditions, as well as oncology. The company leverages its expertise in molecular biology and pharmacology to identify and optimize small molecule and peptide-based candidates that target key pathways in the immune system. Arnika Health aims to address significant unmet medical needs by creating highly selective therapies with improved safety profiles compared to existing treatments. Currently, the company's programs are in the pre-clinical stage, with a focus on validating targets and advancing lead candidates toward IND-enabling studies.